IHS Chemical Week

Archives :: Chem Ideas :: Guest Author

Displaying 101 - 112 of 392 stories.
August 5, 2014
FDA issues warning letter to API producer in China The US FDA issued a warning letter on 9 July to the active pharmaceutical ingredient (API) manufacturing facility of Zhejiang Jiuzhou...
July 29, 2014
Lonza reports huge rise in profits Lonza recorded net profits of 140 million Swiss francs ($155 million) for the first half of 2014 compared with profits of SF41 million in the first...
July 16, 2014
Last week’s passage of H.R. 4007—The Chemical Facility Anti-Terrorism Standards (CFATS) Authorization and Accountability Act of 2014—by the US House of...
July 8, 2014
Medichem opens HPAPI plant in Malta Active pharmaceutical ingredients (API) manufacturer Medichem (Barcelona, Spain) says it has opened a new high potency API (HPAPI) plant in the...
July 1, 2014
Feature FDA tightens control over India’s API manufacturers FDA has, since 2013, issued warning letters to several active pharmaceutical ingredient (API) manufacturing facilities...
June 24, 2014
FDA issues warning letters to API plants in China and India FDA issued separate warning letters earlier this month to the active pharmaceutical ingredient (API) manufacturing...
June 17, 2014
Lonza invests in single-use technology and facility upgrades for clinical ADC manufacturing Lonza says it is investing in technology and facility improvements to its antibody drug...
June 10, 2014
Johnson Matthey's fine chemicals business reports rise in sales Johnson Matthey's (London) fine chemicals business reports a 7.5% rise in sales for the company’s fiscal year...
June 3, 2014
FDA scaling back API facility inspections in US; Socma asks FDA to ensure frequency of inspections does not exceed three years The Bulk Pharmaceuticals Task Force (BPTF), an affiliate...
May 27, 2014
FDA issues warning letter to Sun Pharma's API plant in India FDA issued a warning letter on 7 May to the active pharmaceutical ingredient (API) and finished pharmaceutical...
May 20, 2014
AstraZeneca rejects Pfizer's latest offer AstraZeneca has rejected Pfizer's latest offer to buy AstraZeneca. Pfizer says its offer, which values AstraZeneca at £69 billion ($116...
May 13, 2014
Teva’s API business reports fall in sales The active pharmaceutical ingredient (API) business of Teva Pharmaceutical Industries (PetaŠł• Tiqwa, Israel) reports a 6.7% fall in...
Pages: « Previous  2 3 4 5 6 7 8 9 10 [11] 12 13 14 15 16 17 18 19 20 Next »




RSS Follow us on Twitter Join us on LinkedIn Like us on Facebook Youtube channel
contact us | about us | privacy policy | sitemap

ihsCopyright © IHS, Inc.All rights reserved.Reproduction in whole or in part without permission is prohibited.

North Asia Russia Southeast Asia China India/Pakistan Middle East Eastern Europe Western Europe Central America Canada USA Australia/New Zealand South America Africa